Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/AZN
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

AstraZeneca plc (AZN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

AstraZeneca (AZN) trades at $166.58, up 1.23% on the day, with a bullish technical signal and consistent earnings beats. The company demonstrates strong fundamentals with a 17.02% net income margin and robust revenue growth to $58.74B in 2025. Recent news highlights a $2 billion investment in Summit Therapeutics and EU approval for Trixeo Aerosphere, reinforcing its oncology and respiratory franchises.
The outlook remains positive given analyst consensus of $186.67 price target and 48.78% buy ratings. Key opportunities include pipeline catalysts and strategic collaborations, while risks involve competitive pressures and R&D setbacks. Strong cash flow generation and profitability support further upside potential for investors.
Read full analysis

Key Stats

  • Market Cap
    $257.16B
  • Volume
    1,918,229
  • Sector
    Health
  • 52W High
    $209.48
  • 52W Low
    $148.26
  • Typical Hold Time
    125 Days
  • Enterprise Value
    $284.43B
  • Div Yield
    1.92%
  • Trading Activity
    2% Sell | 98% Buy
$168.61
52W Low: $148.26
29 Sep 2025
52W High: $209.48
17 Feb 2026

Track AstraZeneca plc (AZN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AstraZeneca plc has traded between a low of $148.26 and a high of $209.48, highlighting its annual price range. Buy and sell AstraZeneca plc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Most Recent News

Content is generated by Aura AI

Poolbeg Pharma funds trials through 2028, advancing cancer and obesity drug studies.

Poolbeg Pharma has secured funding to complete its clinical trials through to the second quarter of 2028. The company is currently recruiting patients for its TOPICAL trial of POLB 001, a drug aimed at preventing cytokine release syndrome in cancer p...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
Poolbeg Pharma funds trials through 2028, advancing cancer and obesity drug studies.

Genflow Biosciences to reveal dog longevity trial results and advance glaucoma and liver disease programs

Genflow Biosciences will present full results from its canine ageing trial at the Animal Longevity Summit in Toronto, highlighting the safety and potential health benefits of its GF-1004 treatment aimed at slowing ageing. The company is also progress...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
Genflow Biosciences to reveal dog longevity trial results and advance glaucoma and liver disease programs

Telo Genomics reports promising blood test results for detecting residual multiple myeloma cells, aiming for 2027 commercialization.

Telo Genomics announced new clinical research showing its blood-based TELO-MRD test detects residual multiple myeloma cells more sensitively than traditional bone marrow tests like Adaptive clonoSEQ. The TELO-MRD liquid biopsy identifies circulating ...

Market News
4 hours ago
Newsfile Corp
Bullish
news icon
Telo Genomics reports promising blood test results for detecting residual multiple myeloma cells, aiming for 2027 commercialization.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $257.16B
  • Volume
    1,918,229
  • Sector
    Health
  • 52W High
    $209.48
  • 52W Low
    $148.26
  • Typical Hold Time
    125 Days
  • Enterprise Value
    $284.43B
  • Div Yield
    1.92%
  • Trading Activity
    2% Sell | 98% Buy
$168.61
52W Low: $148.26
29 Sep 2025
52W High: $209.48
17 Feb 2026

Track AstraZeneca plc (AZN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AstraZeneca plc has traded between a low of $148.26 and a high of $209.48, highlighting its annual price range. Buy and sell AstraZeneca plc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!